The Taxus drug-eluting stent: a new paradigm in controlled drug delivery.
about
Optimization of Drug Delivery by Drug-Eluting StentsMacromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary interventionMulti-ligand poly(L-lactic-co-glycolic acid) nanoparticles inhibit activation of endothelial cells.Atomic force microscope infrared spectroscopy of griseofulvin nanocrystals.Vascular inflammation and repair: implications for re-endothelialization, restenosis, and stent thrombosis.New stent design for use in small coronary arteries during percutaneous coronary interventionModelling intravascular delivery from drug-eluting stents with biodurable coating: investigation of anisotropic vascular drug diffusivity and arterial drug distribution.Microfabrication and nanotechnology in stent designModelling the Impact of Atherosclerosis on Drug Release and Distribution from Coronary StentsPromoting vascular regeneration as an alternative to conventional angioplasty-based intervention.Biomedical applications of polyhydroxyalkanoates: an overview of animal testing and in vivo responses.Review of the TAXUS Liberté SR paclitaxel-eluting coronary stent.Multifunctional polyelectrolyte multilayer films: combining mechanical resistance, biodegradability, and bioactivitySimilarities and differences in coatings for magnesium-based stents and orthopaedic implants.The Control of Drug Release and Vascular Endothelialization after Hyaluronic Acid-Coated Paclitaxel Multi-Layer Coating Stent Implantation in Porcine Coronary Restenosis Model.Factors that affect mass transport from drug eluting stents into the artery wall.Pharmacological prevention and management of restenosis.Stents as a platform for drug delivery.Magnetic nanoparticles for targeted vascular delivery.Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.Controlling drug delivery from coronary stents: are we aiming for the right targets?Drug-eluting stents to prevent stent thrombosis and restenosis.Injectable in situ forming controlled release implant composed of a poly-ether-ester-carbonate and applications in the field of chemotherapy.Diffusion-limited binding explains binary dose response for local arterial and tumour drug delivery.Diffuse Interface Methods for Modeling Drug-Eluting Stent Coatings.Impact of flow pulsatility on arterial drug distribution in stent-based therapy.Delivery of paclitaxel from cobalt-chromium alloy surfaces without polymeric carriersEnhanced drug delivery capabilities from stents coated with absorbable polymer and crystalline drugEvaluation of atherosclerotic lesions in cholesterol-fed mice during treatment with paclitaxel in lipid nanoparticles: a magnetic resonance imaging study.Impact of copolymer ratio on drug distribution in styrene-isobutylene-styrene block copolymers.Modeling the transport of drugs eluted from stents: physical phenomena driving drug distribution in the arterial wall.Acrylic copolymers as candidates for drug-eluting coating of vascular stents.The effects of vinblastine on endothelial cells.A polymer-free Paclitaxel eluting coronary stent: effects of solvents, drug concentrations and coating methods.Charged drug delivery by ultrafast exponentially grown weak polyelectrolyte multilayers: amphoteric properties, ultrahigh loading capacity and pH-responsivenessPolymers for Cardiovascular Stent Coatings
P2860
Q28548405-2A162BC2-82D6-4E12-AA4C-DFB5ED1EF0E8Q28654633-BDD26C0E-D308-4E51-8998-763986F2D31CQ30832719-0CED134D-7391-4C47-89BE-93406C54DBF1Q35028683-1122F1BE-31AB-48DE-920B-D8D39058557AQ35927338-F7CFBF89-F14D-4203-93B3-3E5A5E1CA84AQ36160441-C982455A-AB27-4757-AA27-A654A4D71CF6Q36233611-AFEDA874-51B2-4D61-AD41-BCDFA6D6A6F5Q36344315-B1ADA6C3-ED6A-480C-8D57-4D78A501E19FQ36610213-2F60C4F6-0FE2-46F0-8023-21E4FCBB8F9DQ36684479-6EBC6681-002A-46E9-9031-42679DAB4C5CQ36728879-955385E3-15D9-4DF0-AB8F-C38C9E51ADA7Q36759494-FE40F987-F2FB-48E5-9EEB-050A8A682AB5Q36874314-D537C1D0-F088-46D5-8D6C-7A14233A6FAAQ37300521-7FC3EABE-4CB8-48F2-A2CC-336ECC02D0ADQ37619061-4929F886-50ED-485F-83AD-22A8EA70990FQ37705587-68290C33-5DDA-478D-98CE-7892AE9A42B7Q37756979-92E38297-F27E-4B39-88CE-5F23D2284BFDQ37872741-920FE294-3329-44C2-AC67-AB1B254A798FQ37896554-6F41E4FF-CB19-4584-8D30-FC161E280D12Q37947952-FA8E1613-8354-4EC0-B1A4-CED9405418D9Q38543392-D657472D-1A08-4D1A-B6CC-16BE24CE6720Q38633332-542D27A9-4E37-4295-A71F-D263DCF32B9FQ39359989-B820E892-E42A-45E4-999E-1F191ADB90A3Q39976098-D334D366-D37C-4E62-8302-E7D439A091EAQ40726912-64827A53-C5A7-455F-ACA1-7D07E6064717Q41411206-1B160662-C27A-4C81-A4E6-D4D57F67D54AQ41562461-69B656D9-7EAA-465B-96C7-535047AE5D09Q41819741-84C8AAE7-A10E-491D-BF3A-BDD78BD90BDAQ42045229-FA30B155-65AC-4BBC-94D5-9D9E347B62A4Q43716212-E3DA64BE-3E38-4A18-9BD3-016D8D2033A6Q43868016-F09054F4-BC7B-4C95-A199-7ABDAF0FE164Q46228970-DDD03E19-92C5-4B09-B9DE-E36B8B46E210Q46527906-73915351-6F57-46C9-9CA1-C89A24D935EFQ53581114-2E3C778B-1329-49EE-8D01-DE38E8C36C10Q57376561-E7B7B9B0-2C9B-4944-AD14-2E7269409004Q59110902-B137F8D4-4473-45C9-BC1C-BB22C53144F9
P2860
The Taxus drug-eluting stent: a new paradigm in controlled drug delivery.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
The Taxus drug-eluting stent: a new paradigm in controlled drug delivery.
@ast
The Taxus drug-eluting stent: a new paradigm in controlled drug delivery.
@en
type
label
The Taxus drug-eluting stent: a new paradigm in controlled drug delivery.
@ast
The Taxus drug-eluting stent: a new paradigm in controlled drug delivery.
@en
prefLabel
The Taxus drug-eluting stent: a new paradigm in controlled drug delivery.
@ast
The Taxus drug-eluting stent: a new paradigm in controlled drug delivery.
@en
P2093
P1476
The Taxus drug-eluting stent: a new paradigm in controlled drug delivery.
@en
P2093
James J Barry
Kalpana R Kamath
Kathleen M Miller
P304
P356
10.1016/J.ADDR.2006.01.023
P407
P577
2006-03-06T00:00:00Z